Loading clinical trials...

Comparative Effectiveness of Oxiris Hemofilters Versus Conventional Hemofilters in Septic Patients | Clinical Trials | Clareo Health

COMPLETED

Comparative Effectiveness of Oxiris Hemofilters Versus Conventional Hemofilters in Septic Patients

Comparative Effectiveness of Oxiris Filters Versus Conventional Hemofilters in Septic Patients: a Retrospective Cohort Study

NCT06735365•Bakirkoy Dr. Sadi Konuk Research and Training Hospital

View on ClinicalTrials.gov

Summary

We divided patients in 2 groups. First group was the patients who received Oxiris filters during CRRT. Second group was the patiens who have received CRRT filters other than Oxiris. We compared the lab parameters (Urea, Creatinin, Lactate, ABG parameters and SOFA escore with together.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•sepsis diagnosis CRRT indication

Exclusion Criteria

•patients under age of 18

Locations (1)

Bakirkoy Dr Sadi Konuk Research and Training Hospital

Istanbul, Turkey (Türkiye)

Key Dates

Start Date

May 23, 2024

Primary Completion Date

November 1, 2024

Completion Date

December 1, 2024

Last Updated

December 31, 2024

Enrollment

426

ACTUAL participants

Conditions

Sepsis - to Reduce Mortality in the Intensive Care UnitHemodiafiltrationCytokine

Interventions

CRRT

OTHER

Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock

NCT07179276

Sepsis - to Reduce Mortality in the Intensive Care UnitSeptic Shock

View study

RECRUITINGNA

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

NCT07390071

LymphomaMyeloma+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 31, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Comparative Effectiveness of Oxiris Hemofilters Versus Conventional Hemofilters in Septic Patients

Inclusion Criteria

Exclusion Criteria

Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

The Effectiveness of Nano Bio Fusion Gingival Gel (NBF) on Wound Healing at the Palate (Donor Site) After Soft Tissue Graft Surgery Compared to Placebo Gel.

Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

The Effect of Intrathecal Morphine and Erector Spina Plan Block on Serum Cytokine Levels and Chronic Pain in Caesarean Section Surgery